Presumably, a small subpopulation of the IDC-P at baseline (B2) also harbored the second loss to PTEN and the nonsense mutation to TP53, as these were observed in the IDC-P on the right side (R2), which in turn comprised the largest volume of all residual tumor. The gene discussed is PTEN; the disease is neoplasm.